Literature DB >> 2254446

Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.

S L Reed1, I Gigli.   

Abstract

Activation of complement by Entamoeba histolytica may be initiated by the extracellular 56-kD neutral cysteine proteinase which cleaves the alpha chain of C3. To determine the relationship between the fluid-phase activation of complement and our observation that only strains isolated from patients with invasive disease are resistant to complement-mediated lysis, we investigated the fate of C3 with recent amebic isolates. When 125I-C3 was incubated with trophozoites in serum, C3 in the fluid phase was cleaved to C3b or C3bi, but the alpha chain of the C3 molecules on the cell surface appeared intact. Since the lysis of nonpathogenic strains takes place in the absence of bound C3b, we demonstrated that this reaction occurs by reactive lysis initiated in the fluid phase: (a) the killing of nonpathogenic strains was enhanced when alternative pathway activation was accelerated by the addition of cobra venom factor; (b) non-pathogenic strains were lysed by purified terminal components; and (c) sera incubated with pathogenic E. histolytica produced passive lysis of chicken erythrocytes. These results demonstrate for the first time that complement-sensitive E. histolytica are lysed by activation of the terminal complement components in the fluid phase where the 56-kD neutral cysteine proteinase cleaves C3, and not by the surface deposition of activated C3.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254446      PMCID: PMC329813          DOI: 10.1172/JCI114911

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9.

Authors:  J N Goldman; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

2.  A comparison of the virulence of nine strains of axenically cultivated E. histolytica in hamster liver.

Authors:  L S Diamond; B P Phillips; I L Bartgis
Journal:  Arch Invest Med (Mex)       Date:  1974

3.  A simplified method for the preparation of EAC14 intermediate cells using human serum treated with methylprednisolone.

Authors:  F Kitamura; K Shimada; T Suzuki; K Nishioka
Journal:  J Immunol Methods       Date:  1985-12-27       Impact factor: 2.303

Review 4.  Cytopathogenicity of Entamoeba histolytica.

Authors:  C Gitler; E Calef; I Rosenberg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1984-11-13       Impact factor: 6.237

5.  Reaction mechanisms of nascent C567 (reactive lysis). II. Killing of a rough form of Escherichia coli by C567, C8, and C9.

Authors:  J N Goldman; K F Austen
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

6.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

7.  Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Authors:  J Calderon; R D Schreiber
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  Isolation of human complement factors C3, C5 and H.

Authors:  A Lundwall; G Eggertsen
Journal:  J Immunol Methods       Date:  1985-07-16       Impact factor: 2.303

9.  Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.

Authors:  A E Davis; R A Harrison; P J Lachmann
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

10.  Lysis of erythrocytes by complement in the absence of antibody.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

View more
  22 in total

Review 1.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  The invasiveness of Entamoeba histolytica - a continuing enigma.

Authors:  J P Ackers
Journal:  Clin Mol Pathol       Date:  1996-08

Review 3.  Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.

Authors:  Xiaoti Guo; Eric Houpt; William A Petri
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

Review 4.  Complement evasion by parasites: search for "Achilles' heel".

Authors:  Z Fishelson
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 5.  Biting Off What Can Be Chewed: Trogocytosis in Health, Infection, and Disease.

Authors:  Akhila Bettadapur; Hannah W Miller; Katherine S Ralston
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 6.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica.

Authors:  L L Braga; H Ninomiya; J J McCoy; S Eacker; T Wiedmer; C Pham; S Wood; P J Sims; W A Petri
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 8.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

9.  Amebic cysteine proteinase 2 (EhCP2) plays either a minor or no role in tissue damage in acute experimental amebic liver abscess in hamsters.

Authors:  Alfonso Olivos-García; Augusto González-Canto; Rosario López-Vancell; Maria del Carmen García de León; Eusebio Tello; Mario Nequiz-Avendaño; Irmgard Montfort; Ruy Pérez-Tamayo
Journal:  Parasitol Res       Date:  2003-02-27       Impact factor: 2.289

10.  Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).

Authors:  C Hamelmann; B Urban; B Foerster; R D Horstmann
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.